PSquared Asset Management »

Crispr Therapeutics shares owned by PSquared Asset Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by PSquared Asset Management from 13F filings

Historical chart of PSquared Asset Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by PSquared Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by PSquared Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $61k 3.5k 17.50
2023-06-30 $1.7M 4.1k 409.79

More positions owned by PSquared Asset Management

Activision Blizzard
Horizon Therapeutics Pub L SHS
Seagen
PNM Resources (PNM)
Exelixis Put Put Option (EXEL)
United States Steel Corporation (X)
Capri Holdings SHS (CPRI)
Sovos Brands
Nextgen Healthcare
National Cinemedia Com New (NCMI)
Crispr Therapeutics Call Call Option (CRSP)
Halliburton Put Put Option (HAL)
Qiagen Nv Call Call Option
Schlumberger Put Put Option (SLB)

View all positions for PSquared Asset Management

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics